AIA slice of Cerba Healthcare's €450 million revolving credit facility is up for sale as the EQT AB-backed private laboratories company moves toward court-supervised restructuring to tackle its €5 billion ($5.8 billion) debt pile. One or more lenders are seeking to auction approximately €28 million of the RCF, with bids from fund managers due Wednesday. The confidential auction requires interested parties to submit offers without public disclosure.

The restructuring effort targets a significant reduction in Cerba's debt burden, with the €28 million auction representing a strategic step to restructure liabilities while maintaining operational continuity. Bidders must act swiftly as the deadline approaches, with the process overseen by legal and financial advisors to ensure compliance with court-supervised parameters.

Cerba Healthcare, headquartered in St Ouen l'Aumone, France, operates a network of private laboratories across Europe. The company's debt restructuring is being managed through formal legal proceedings, with stakeholders coordinating to balance creditor recovery against the company's long-term viability. All parties remain focused on achieving a sustainable resolution by the end of the restructuring timeline.